Showing results (161-170 of 313) with videos related to

Sort By:
Pageof 32
Journal of Diabetes and Its Complications|August 28, 2001
Type 1 diabetes with no diabetic complications, 62 years laterS Feldman-Billard, S Limon, Y Morin, et al.
Biochimica Et Biophysica Acta|July 25, 1978
Polyisoprenoid amphiphilic compounds as inhibitors of squalene synthesis and other microsomal enzymesA Bertolino, L J Altman, J Vasak, et al.
Scandinavian Journal of Immunology|May 1, 1983
Genetic control of murine antibody-dependent cell-mediated cytotoxicity. Partial identity with the genetic control of NK activityJ Altman, P Bardos, R Van der Gaag, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant miceS A Bayer, K V Wills, L C Triarhou, et al.
Annals of Ophthalmology|May 1, 1986
The breakdown of polypropylene in the human eye: is it clinically significant?A J Altman, R A Gorn, J Craft, et al.
Physiology & Behavior|November 1, 1992
Maudsley reactive (MR/Har) and nonreactive (MNRA/Har) rats: performance in an operant conflict paradigmR L Commissaris, L Franklin, J S Verbanac, et al.
Journal of Pediatric Hematology/Oncology|December 18, 1998
Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case reportS K Bergstrom, E Gillan, J J Quinn, et al.
Journal of Endocrinological Investigation|July 1, 1980
The GnRH test in idiopathic hemochromatosisJ J Altman, M Zygelman, M Roger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell diseaseJ R Votano, J Altman, M Wilchek, et al.
Pageof 32